Duncan Gregory Scott 4
4 · Dogwood Therapeutics, Inc. · Filed Dec 5, 2025
Insider Transaction Report
Form 4
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (right to buy)
2025-12-04+460,000→ 460,000 totalExercise: $6.14Exp: 2035-12-04→ Common Stock (460,000 underlying)
Footnotes (1)
- [F1]The stock option vests one-third on December 4, 2026 and 1/24th monthly thereafter.